MilliporeSigma’s new BioContinuum Seed Train Platform offering enables a fully closed bioprocessing environment for both fed-batch and perfusion N-production. On June 27, 2022, MilliporeSigma, the US ...
Cell culture-produced adeno-associated viral (AAV) vectors have gained momentum as one of the most effective gene and protein delivery tools and are an integral part of both vaccine production and ...
Current fed-batch based seed train strategies—from out of freeze to cell culture cultivation in production bioreactors—are cumbersome and add significant time, cost, and manual labor. Learn how to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results